Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient.

Researcher Access to Clinical Data

NIAID's cloud-based, secure data platform enables sharing of anonymous patient-level clinical data to help generate new knowledge to treat and prevent infectious diseases such as COVID-19.

This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (blue/pink) cultured in the lab.

Novel Coronavirus

NIAID is conducting and supporting research on SARS CoV-2 and the disease COVID-19.

Gloved hand holding a vial of Johnson and Johnson COVID-19 vaccine candidate

Science News Highlights of 2020

In 2020, NIAID and its global partners rapidly leveraged their scientific infrastructure and expertise to conduct critical research to address the coronavirus disease 2019 (COVID-19) pandemic.

Featured Areas of Research

Diseases & Conditions

Antimicrobial Resistance
HIV/AIDS
Coronaviruses

Director, Dr. Anthony S. Fauci

About the Director

Anthony Fauci

Videocast:

NIH COVID-19 Vaccine Kick-Off Event at the NIH Clinical Center

Publication:

The Story Behind COVID-19 Vaccines

Funding Opportunities

Get the latest information on...

Learn more about...

Newsroom